| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.86 | 0.005 | 0.867 | Caspase 9 stimulant | 0.867 0.004 CID_154700137 | CID_154700137 | |
| 0.731 | 0.003 | 0.731 | Peroxidase inhibitor | 0.146 0.08 CID_154700137 | ||
| 0.727 | 0.011 | 0.727 | 15-Lipoxygenase inhibitor | |||
| 0.72 | 0.005 | 0.805 | Free radical scavenger | 0.805 0.004 CID_154700137 | CID_154700137 | |
| 0.738 | 0.025 | 0.768 | Apoptosis agonist | 0.768 0.02 CID_154700137 | CID_154700137 | |
| 0.709 | 0.008 | 0.709 | Aldehyde oxidase inhibitor | |||
| 0.707 | 0.007 | 0.707 | 12-Lipoxygenase inhibitor | |||
| 0.687 | 0.01 | 0.687 | Aryl hydrocarbon receptor agonist | 0.204 0.1 CID_154700137 | ||
| 0.681 | 0.006 | 0.831 | Antioxidant | 0.831 0.004 CID_154700137 | CID_154700137 | |
| 0.658 | 0.003 | 0.658 | Cystathionine beta-synthase inhibitor | 0.596 0.003 CID_154700137 | ||
| 0.631 | 0.008 | 0.783 | Histamine release inhibitor | 0.783 0.004 CID_154700137 | CID_154700137 | |
| 0.618 | 0.009 | 0.723 | 5 Hydroxytryptamine release inhibitor | 0.723 0.004 CID_154700137 | CID_154700137 | |
| 0.59 | 0.007 | 0.59 | Superoxide dismutase inhibitor | |||
| 0.628 | 0.048 | 0.866 | Alpha-glucosidase inhibitor | 0.866 0.01 CID_154700137 | CID_154700137 | |
| 0.587 | 0.008 | 0.62 | Hypoxia-inducible factor 1 alpha inhibitor | 0.62 0.007 CID_154700137 | CID_154700137 | |
| 0.574 | 0.012 | 0.574 | Lipoxygenase inhibitor | |||
| 0.555 | 0.014 | 0.555 | Caspase 3 stimulant | 0.514 0.018 CID_154700137 | ||
| 0.541 | 0.004 | 0.541 | Breast cancer-resistant protein inhibitor | 0.096 0.059 CID_154700137 | ||
| 0.534 | 0.004 | 0.534 | NADPH oxidase inhibitor | 0.519 0.004 CID_154700137 | ||
| 0.558 | 0.037 | 0.792 | Transcription factor NF kappa B inhibitor | 0.792 0.013 CID_154700137 | CID_154700137 | |
| 0.5 | 0.014 | 0.5 | Amyloid beta aggregation inhibitor | 0.406 0.024 CID_154700137 | ||
| 0.508 | 0.024 | 0.508 | GABA C receptor rho-3 antagonist | |||
| 0.482 | 0.009 | 0.482 | P-glycoprotein inhibitor | 0.291 0.031 CID_154700137 | ||
| 0.481 | 0.01 | 0.481 | Pyruvate kinase inhibitor | 0.194 0.085 CID_154700137 | ||
| 0.472 | 0.003 | 0.472 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.125 0.027 CID_154700137 | ||
| 0.469 | 0.009 | 0.783 | Monophenol monooxygenase inhibitor | 0.783 0.003 CID_154700137 | CID_154700137 | |
| 0.475 | 0.024 | 0.628 | Apoptosis antagonist | 0.628 0.007 CID_154700137 | CID_154700137 | |
| 0.455 | 0.005 | 0.455 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.331 0.016 CID_154700137 | ||
| 0.447 | 0.005 | 0.447 | Interleukin 4 antagonist | 0.235 0.015 CID_154700137 | ||
| 0.462 | 0.021 | 0.83 | Vasodilator, coronary | 0.83 0.003 CID_154700137 | CID_154700137 | |
| 0.485 | 0.045 | 0.485 | Prostaglandin dehydrogenase inhibitor | |||
| 0.456 | 0.015 | 0.529 | Vasodilator | 0.529 0.01 CID_154700137 | CID_154700137 | |
| 0.446 | 0.007 | 0.446 | MAO A inhibitor | |||
| 0.445 | 0.01 | 0.445 | Dual specificity phosphatase inhibitor | |||
| 0.444 | 0.009 | 0.444 | MAO inhibitor | |||
| 0.457 | 0.026 | 0.457 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.433 | 0.009 | 0.455 | Topoisomerase II inhibitor | 0.455 0.008 CID_154700137 | CID_154700137 | |
| 0.424 | 0.004 | 0.424 | Topoisomerase II alpha inhibitor | 0.387 0.005 CID_154700137 | ||
| 0.419 | 0.004 | 0.618 | Xanthine oxidase inhibitor | 0.618 0.003 CID_154700137 | CID_154700137 | |
| 0.45 | 0.036 | 0.45 | 5 Hydroxytryptamine release stimulant | 0.352 0.056 CID_154700137 | ||
| 0.423 | 0.012 | 0.423 | Dual specificity phosphatase 3 inhibitor | |||
| 0.424 | 0.015 | 0.424 | Transcription factor STAT inhibitor | |||
| 0.417 | 0.008 | 0.501 | DNA methyltransferase I inhibitor | 0.501 0.005 CID_154700137 | CID_154700137 | |
| 0.494 | 0.09 | 0.808 | Antiinflammatory | 0.808 0.014 CID_154700137 | CID_154700137 | |
| 0.419 | 0.016 | 0.419 | RNA-directed DNA polymerase inhibitor | 0.305 0.03 CID_154700137 | ||
| 0.408 | 0.011 | 0.613 | Melanin inhibitor | 0.613 0.004 CID_154700137 | CID_154700137 | |
| 0.409 | 0.013 | 0.409 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.395 | 0.004 | 0.494 | Carbonic anhydrase XIII inhibitor | 0.494 0.003 CID_154700137 | CID_154700137 | |
| 0.398 | 0.008 | 0.527 | NOS3 expression enhancer | 0.527 0.005 CID_154700137 | CID_154700137 | |
| 0.412 | 0.024 | 0.609 | Nitric oxide antagonist | 0.609 0.009 CID_154700137 | CID_154700137 | |
| 0.393 | 0.01 | 0.735 | Amylase inhibitor | 0.735 0.003 CID_154700137 | CID_154700137 | |
| 0.387 | 0.004 | 0.387 | Carbonic anhydrase III inhibitor | 0.215 0.014 CID_154700137 | ||
| 0.384 | 0.009 | 0.488 | Protein kinase stimulant | 0.488 0.004 CID_154700137 | CID_154700137 | |
| 0.387 | 0.012 | 0.493 | DNA methylase inhibitor | 0.493 0.006 CID_154700137 | CID_154700137 | |
| 0.399 | 0.027 | 0.604 | Tumour necrosis factor alpha release inhibitor | 0.604 0.007 CID_154700137 | CID_154700137 | |
| 0.366 | 0.004 | 0.366 | Carbonic anhydrase VI inhibitor | 0.166 0.018 CID_154700137 | ||
| 0.369 | 0.011 | 0.469 | Lipid peroxidase inhibitor | 0.469 0.006 CID_154700137 | CID_154700137 | |
| 0.368 | 0.013 | 0.368 | Tubulin antagonist | |||
| 0.384 | 0.032 | 0.581 | Antiamyloidogenic | 0.581 0.009 CID_154700137 | CID_154700137 | |
| 0.351 | 0.003 | 0.351 | Creatine kinase inhibitor | 0.087 0.076 CID_154700137 | ||
| 0.348 | 0.008 | 0.348 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.372 | 0.035 | 0.523 | DNA damaging | 0.523 0.012 CID_154700137 | CID_154700137 | |
| 0.336 | 0.005 | 0.336 | Telomerase inhibitor | |||
| 0.336 | 0.006 | 0.336 | Succinate dehydrogenase inhibitor | 0.164 0.089 CID_154700137 | ||
| 0.363 | 0.035 | 0.725 | Hypoglycemic | 0.725 0.005 CID_154700137 | CID_154700137 | |
| 0.385 | 0.06 | 0.385 | Vasodilator, peripheral | 0.308 0.093 CID_154700137 | ||
| 0.34 | 0.021 | 0.584 | Non-steroidal antiinflammatory agent | 0.584 0.005 CID_154700137 | CID_154700137 | |
| 0.365 | 0.048 | 0.603 | Spasmolytic | 0.603 0.013 CID_154700137 | CID_154700137 | |
| 0.314 | 0.005 | 0.314 | Electron transport complex I inhibitor | 0.117 0.051 CID_154700137 | ||
| 0.323 | 0.015 | 0.323 | Protein-tyrosine phosphatase inhibitor | 0.242 0.033 CID_154700137 | ||
| 0.321 | 0.013 | 0.321 | Cytokine production inhibitor | |||
| 0.389 | 0.082 | 0.695 | Antibacterial | 0.695 0.009 CID_154700137 | CID_154700137 | |
| 0.309 | 0.004 | 0.309 | Multidrug resistance-associated protein 1 inhibitor | 0.231 0.005 CID_154700137 | ||
| 0.313 | 0.01 | 0.477 | Alkaline phosphatase inhibitor | 0.477 0.004 CID_154700137 | CID_154700137 | |
| 0.314 | 0.015 | 0.314 | Tumour necrosis factor antagonist | |||
| 0.31 | 0.012 | 0.31 | Acetylcholinesterase inhibitor | 0.139 0.062 CID_154700137 | ||
| 0.411 | 0.114 | 0.411 | DNA polymerase beta inhibitor | |||
| 0.319 | 0.025 | 0.319 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.304 | 0.01 | 0.361 | Nitric-oxide synthase stimulant | 0.361 0.004 CID_154700137 | CID_154700137 | |
| 0.354 | 0.061 | 0.354 | Streptokinase A inhibitor | |||
| 0.316 | 0.025 | 0.592 | Hepatoprotectant | 0.592 0.005 CID_154700137 | CID_154700137 | |
| 0.303 | 0.013 | 0.303 | MAO B inhibitor | |||
| 0.304 | 0.016 | 0.304 | Amyloid beta precursor protein antagonist | |||
| 0.326 | 0.041 | 0.326 | Transcription factor STAT3 inhibitor | 0.177 0.168 CID_154700137 | ||
| 0.277 | 0.005 | 0.277 | Macrophage migration inhibitory factor inhibitor | |||
| 0.332 | 0.063 | 0.332 | Calcium channel activator | |||
| 0.302 | 0.033 | 0.463 | Platelet adhesion inhibitor | 0.463 0.007 CID_154700137 | CID_154700137 | |
| 0.387 | 0.121 | 0.387 | DNA directed DNA polymerase inhibitor | |||
| 0.268 | 0.006 | 0.268 | HIV-1 integrase (3'-Processing) inhibitor | 0.107 0.023 CID_154700137 | ||
| 0.269 | 0.013 | 0.269 | 5-Lipoxygenase inhibitor | |||
| 0.299 | 0.05 | 0.756 | Angiogenesis stimulant | 0.756 0.004 CID_154700137 | CID_154700137 | |
| 0.254 | 0.005 | 0.378 | Photosensitizer | 0.378 0.003 CID_154700137 | CID_154700137 | |
| 0.257 | 0.011 | 0.257 | Carbonic anhydrase XV inhibitor | |||
| 0.25 | 0.006 | 0.25 | HIV-1 integrase (Strand Transfer) inhibitor | 0.095 0.025 CID_154700137 | ||
| 0.264 | 0.022 | 0.264 | Heat shock protein 90 alpha antagonist | |||
| 0.355 | 0.113 | 0.355 | Calcium channel L-type activator | |||
| 0.266 | 0.025 | 0.266 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.283 | 0.049 | 0.283 | Antimitotic | |||
| 0.246 | 0.013 | 0.258 | Mannose-6-phosphate isomerase inhibitor | 0.258 0.01 CID_154700137 | CID_154700137 | |
| 0.252 | 0.02 | 0.252 | Heat shock protein 90 antagonist | |||
| 0.312 | 0.081 | 0.746 | Antithrombotic | 0.746 0.006 CID_154700137 | CID_154700137 | |
| 0.233 | 0.004 | 0.233 | Xanthine dehydrogenase inhibitor | 0.099 0.016 CID_154700137 | ||
| 0.326 | 0.099 | 0.529 | Immunosuppressant | 0.529 0.026 CID_154700137 | CID_154700137 | |
| 0.243 | 0.017 | 0.243 | Chelator | 0.105 0.07 CID_154700137 | ||
| 0.258 | 0.033 | 0.258 | Mcl-1 antagonist | |||
| 0.312 | 0.088 | 0.312 | Thyroid hormone antagonist | |||
| 0.235 | 0.015 | 0.235 | GABA C receptor rho-2 antagonist | |||
| 0.234 | 0.018 | 0.234 | Protein kinase (CK2) alpha inhibitor | |||
| 0.219 | 0.005 | 0.219 | Histone deacetylase SIRT1 stimulant | 0.17 0.006 CID_154700137 | ||
| 0.219 | 0.005 | 0.219 | Histone deacetylase stimulant | 0.17 0.006 CID_154700137 | ||
| 0.228 | 0.014 | 0.228 | Toll-Like receptor 2 antagonist | 0.115 0.083 CID_154700137 | ||
| 0.25 | 0.038 | 0.262 | Neurotrophic factor enhancer | 0.262 0.032 CID_154700137 | CID_154700137 | |
| 0.217 | 0.006 | 0.234 | Aldose reductase inhibitor | 0.234 0.005 CID_154700137 | CID_154700137 | |
| 0.298 | 0.089 | 0.298 | Thyroid hormone beta antagonist | |||
| 0.267 | 0.06 | 0.267 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.226 | 0.022 | 0.226 | Protein-tyrosine phosphatase 1B inhibitor | 0.203 0.028 CID_154700137 | ||
| 0.208 | 0.006 | 0.208 | CDC25A inhibitor | 0.08 0.043 CID_154700137 | ||
| 0.213 | 0.011 | 0.213 | Uric acid excretion stimulant | 0.202 0.013 CID_154700137 | ||
| 0.234 | 0.033 | 0.234 | Cholinergic | |||
| 0.205 | 0.005 | 0.205 | Heat shock protein 70 antagonist | 0.196 0.007 CID_154700137 | ||
| 0.202 | 0.005 | 0.202 | Myeloperoxidase inhibitor | |||
| 0.206 | 0.01 | 0.206 | Protein kinase C zeta inhibitor | |||
| 0.197 | 0.003 | 0.197 | D-Ala-D-Ala ligase inhibitor | |||
| 0.202 | 0.009 | 0.202 | Estrogen receptor beta antagonist | |||
| 0.27 | 0.079 | 0.27 | Insulysin inhibitor | |||
| 0.201 | 0.013 | 0.201 | Estrogen antagonist | 0.105 0.087 CID_154700137 | ||
| 0.192 | 0.004 | 0.192 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.143 0.008 CID_154700137 | ||
| 0.223 | 0.04 | 0.223 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.203 | 0.034 | 0.299 | Insulin secretagoues | 0.299 0.013 CID_154700137 | CID_154700137 | |
| 0.174 | 0.006 | 0.174 | Thioredoxin reductase inhibitor | 0.092 0.038 CID_154700137 | ||
| 0.19 | 0.023 | 0.51 | Cyclooxygenase 3 inhibitor | 0.51 0.003 CID_154700137 | CID_154700137 | |
| 0.182 | 0.015 | 0.572 | Beta glucuronidase inhibitor | 0.572 0.003 CID_154700137 | CID_154700137 | |
| 0.19 | 0.023 | 0.19 | Butyrylcholinesterase inhibitor | |||
| 0.176 | 0.01 | 0.176 | Aromatase inhibitor | |||
| 0.2 | 0.033 | 0.2 | Arachidonic acid antagonist | 0.124 0.12 CID_154700137 | ||
| 0.241 | 0.076 | 0.241 | Dyrk kinase inhibitor | |||
| 0.192 | 0.028 | 0.314 | Topoisomerase I inhibitor | 0.314 0.01 CID_154700137 | CID_154700137 | |
| 0.184 | 0.022 | 0.184 | Protein kinase (CK2) inhibitor | |||
| 0.17 | 0.009 | 0.181 | T cell inhibitor | 0.181 0.008 CID_154700137 | CID_154700137 | |
| 0.175 | 0.015 | 0.378 | DNA repair enzyme inhibitor | 0.378 0.004 CID_154700137 | CID_154700137 | |
| 0.163 | 0.005 | 0.163 | Aryl hydrocarbon receptor antagonist | |||
| 0.161 | 0.003 | 0.161 | Glutamate (mGluR7) antagonist | 0.073 0.037 CID_154700137 | ||
| 0.194 | 0.037 | 0.194 | Cyclooxygenase 1 inhibitor | 0.139 0.063 CID_154700137 | ||
| 0.214 | 0.06 | 0.214 | Insulin sensitizer | 0.201 0.072 CID_154700137 | ||
| 0.172 | 0.018 | 0.172 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.157 | 0.004 | 0.157 | Potassium channel Kv1.3 blocker | |||
| 0.212 | 0.061 | 0.212 | I kappa B kinase epsilon inhibitor | |||
| 0.182 | 0.033 | 0.189 | Aldehyde dehydrogenase inhibitor | 0.189 0.03 CID_154700137 | CID_154700137 | |
| 0.165 | 0.015 | 0.165 | DOPA decarboxylase inhibitor | |||
| 0.195 | 0.047 | 0.195 | Phospholipase C inhibitor | 0.165 0.08 CID_154700137 | ||
| 0.153 | 0.006 | 0.153 | CDC25B inhibitor | |||
| 0.169 | 0.022 | 0.169 | Potassium channel (Ca-activated) activator | |||
| 0.156 | 0.01 | 0.156 | Interleukin 5 antagonist | 0.137 0.015 CID_154700137 | ||
| 0.168 | 0.021 | 0.168 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.161 | 0.016 | 0.161 | Transcription factor STAT6 inhibitor | |||
| 0.223 | 0.079 | 0.223 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.157 | 0.013 | 0.157 | Carbonic anhydrase V inhibitor | |||
| 0.158 | 0.02 | 0.158 | Urease inhibitor | |||
| 0.185 | 0.047 | 0.35 | Interferon gamma antagonist | 0.35 0.014 CID_154700137 | CID_154700137 | |
| 0.153 | 0.016 | 0.153 | CYP2A6 inhibitor | |||
| 0.142 | 0.005 | 0.142 | Protease activated receptor antagonist | 0.055 0.054 CID_154700137 | ||
| 0.143 | 0.006 | 0.143 | Carbonic anhydrase VII inhibitor | 0.085 0.012 CID_154700137 | ||
| 0.16 | 0.023 | 0.348 | AMP-activated protein kinase stimulant | 0.348 0.004 CID_154700137 | CID_154700137 | |
| 0.16 | 0.024 | 0.16 | Ca2+-transporting ATPase inhibitor | 0.155 0.033 CID_154700137 | ||
| 0.156 | 0.021 | 0.156 | Calcium antagonist | |||
| 0.178 | 0.043 | 0.178 | Bone formation stimulant | 0.137 0.071 CID_154700137 | ||
| 0.143 | 0.009 | 0.143 | HIV-1 integrase inhibitor | 0.068 0.051 CID_154700137 | ||
| 0.14 | 0.006 | 0.14 | CD45 antagonist | |||
| 0.152 | 0.02 | 0.157 | Alcohol dehydrogenase inhibitor | 0.157 0.018 CID_154700137 | CID_154700137 | |
| 0.144 | 0.012 | 0.144 | Carbonic anhydrase VA inhibitor | |||
| 0.174 | 0.042 | 0.174 | CF transmembrane conductance regulator agonist | |||
| 0.2 | 0.07 | 0.2 | Histone acetyltransferase inhibitor | |||
| 0.157 | 0.028 | 0.157 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.136 | 0.008 | 0.136 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.179 | 0.051 | 0.193 | Cyclooxygenase inhibitor | 0.193 0.045 CID_154700137 | CID_154700137 | |
| 0.129 | 0.005 | 0.129 | Fatty acid synthase inhibitor | 0.069 0.026 CID_154700137 | ||
| 0.127 | 0.003 | 0.127 | Dopamine D5 agonist | |||
| 0.152 | 0.031 | 0.17 | Mucolytic | 0.17 0.022 CID_154700137 | CID_154700137 | |
| 0.136 | 0.017 | 0.136 | Keratolytic | |||
| 0.153 | 0.034 | 0.479 | Expectorant | 0.479 0.004 CID_154700137 | CID_154700137 | |
| 0.248 | 0.13 | 0.248 | Sodium/bile acid cotransporter inhibitor | |||
| 0.132 | 0.015 | 0.132 | Beta tubulin antagonist | |||
| 0.132 | 0.015 | 0.132 | Estrogen receptor alpha antagonist | |||
| 0.194 | 0.078 | 0.194 | Anesthetic general | 0.189 0.081 CID_154700137 | ||
| 0.123 | 0.008 | 0.123 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.138 | 0.029 | 0.187 | Toll-Like receptor 4 antagonist | 0.187 0.008 CID_154700137 | CID_154700137 | |
| 0.115 | 0.007 | 0.115 | Heat shock protein 90 beta antagonist | |||
| 0.276 | 0.169 | 0.276 | Transcription factor inhibitor | |||
| 0.139 | 0.033 | 0.284 | Antineoplastic antibiotic | 0.284 0.011 CID_154700137 | CID_154700137 | |
| 0.142 | 0.037 | 0.142 | TRPA1 agonist | 0.1 0.088 CID_154700137 | ||
| 0.139 | 0.034 | 0.39 | Mediator release inhibitor | 0.39 0.005 CID_154700137 | CID_154700137 | |
| 0.13 | 0.025 | 0.159 | Thioredoxin inhibitor | 0.159 0.014 CID_154700137 | CID_154700137 | |
| 0.156 | 0.054 | 0.156 | Adenylate cyclase stimulant | |||
| 0.119 | 0.018 | 0.119 | mTOR complex 2 inhibitor | |||
| 0.234 | 0.137 | 0.474 | Cholesterol antagonist | 0.474 0.037 CID_154700137 | CID_154700137 | |
| 0.156 | 0.061 | 0.482 | Hemostatic | 0.482 0.005 CID_154700137 | CID_154700137 | |
| 0.1 | 0.004 | 0.1 | Ryanodine receptor antagonist | |||
| 0.129 | 0.035 | 0.129 | Sphingomyelinase inhibitor | 0.108 0.052 CID_154700137 | ||
| 0.144 | 0.05 | 0.296 | Alkylator | 0.296 0.013 CID_154700137 | CID_154700137 | |
| 0.128 | 0.034 | 0.128 | GABA C receptor rho-1 antagonist | |||
| 0.148 | 0.055 | 0.167 | Cyclooxygenase 2 inhibitor | 0.167 0.043 CID_154700137 | CID_154700137 | |
| 0.164 | 0.071 | 0.164 | Neurotensin receptor agonist | |||
| 0.167 | 0.075 | 0.307 | ATPase inhibitor | 0.307 0.005 CID_154700137 | CID_154700137 | |
| 0.115 | 0.023 | 0.115 | Cyclin B3 inhibitor | |||
| 0.184 | 0.093 | 0.184 | Interleukin antagonist | |||
| 0.122 | 0.032 | 0.122 | Androgen antagonist | |||
| 0.096 | 0.008 | 0.096 | Transcription factor RelA inhibitor | |||
| 0.103 | 0.015 | 0.103 | Alpha tubulin antagonist | |||
| 0.183 | 0.096 | 0.183 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.129 | 0.044 | 0.129 | Nav1.5 sodium channel blocker | |||
| 0.135 | 0.05 | 0.187 | DNA intercalator | 0.187 0.03 CID_154700137 | CID_154700137 | |
| 0.102 | 0.018 | 0.102 | Alcohol oxidase inhibitor | |||
| 0.096 | 0.012 | 0.122 | Carbonic anhydrase XIV inhibitor | 0.122 0.007 CID_154700137 | CID_154700137 | |
| 0.135 | 0.052 | 0.17 | Beta amyloid protein antagonist | 0.17 0.028 CID_154700137 | CID_154700137 | |
| 0.104 | 0.022 | 0.104 | Potassium channel large-conductance Ca-activated activator | |||
| 0.176 | 0.095 | 0.217 | Psychostimulant | 0.217 0.071 CID_154700137 | CID_154700137 | |
| 0.112 | 0.032 | 0.112 | Phosphodiesterase 4D inhibitor | |||
| 0.111 | 0.033 | 0.111 | Ornithine decarboxylase inhibitor | 0.087 0.059 CID_154700137 | ||
| 0.095 | 0.019 | 0.095 | Estrogen agonist | 0.081 0.023 CID_154700137 | ||
| 0.16 | 0.085 | 0.16 | Death-associated protein kinase 2 inhibitor | |||
| 0.199 | 0.125 | 0.364 | DNA synthesis inhibitor | 0.364 0.027 CID_154700137 | CID_154700137 | |
| 0.118 | 0.045 | 0.261 | UDP-glucose 4-epimerase inhibitor | 0.261 0.012 CID_154700137 | CID_154700137 | |
| 0.133 | 0.061 | 0.133 | Vanilloid 1 agonist | 0.126 0.074 CID_154700137 | ||
| 0.106 | 0.034 | 0.119 | Glutamate release inhibitor | 0.119 0.023 CID_154700137 | CID_154700137 | |
| 0.102 | 0.031 | 0.102 | Histidine decarboxylase inhibitor | |||
| 0.095 | 0.024 | 0.095 | Leukotriene antagonist | 0.073 0.038 CID_154700137 | ||
| 0.084 | 0.014 | 0.084 | Estrogen receptor beta agonist | 0.026 0.025 CID_154700137 | ||
| 0.135 | 0.065 | 0.248 | Alpha-N-acetylglucosaminidase inhibitor | 0.248 0.023 CID_154700137 | CID_154700137 | |
| 0.101 | 0.032 | 0.101 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.111 | 0.044 | 0.111 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.097 | 0.029 | 0.097 | Phosphodiesterase V inhibitor | |||
| 0.106 | 0.038 | 0.187 | NADH dehydrogenase inhibitor | 0.187 0.012 CID_154700137 | CID_154700137 | |
| 0.148 | 0.081 | 0.274 | Hexokinase inhibitor | 0.274 0.013 CID_154700137 | CID_154700137 | |
| 0.126 | 0.06 | 0.126 | Cholesterol synthesis inhibitor | |||
| 0.095 | 0.029 | 0.095 | Adenosine A3 receptor antagonist | |||
| 0.114 | 0.049 | 0.114 | Bronchodilator | |||
| 0.095 | 0.031 | 0.095 | Estrogen-related receptor beta agonist | |||
| 0.069 | 0.004 | 0.069 | Vanilloid 3 antagonist | |||
| 0.177 | 0.114 | 0.36 | Cyclic AMP phosphodiesterase inhibitor | 0.36 0.023 CID_154700137 | CID_154700137 | |
| 0.093 | 0.03 | 0.093 | Phosphodiesterase 5A inhibitor | |||
| 0.143 | 0.081 | 0.143 | Phospholipase A2 inhibitor | |||
| 0.095 | 0.034 | 0.095 | Caspase 7 inhibitor | |||
| 0.117 | 0.056 | 0.117 | GABA C receptor antagonist | |||
| 0.069 | 0.008 | 0.069 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.196 | 0.136 | 0.196 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.082 | 0.023 | 0.082 | Protein kinase C eta inhibitor | |||
| 0.083 | 0.023 | 0.083 | Purinergic P2X1 antagonist | |||
| 0.14 | 0.083 | 0.14 | Cytidine deaminase inhibitor | |||
| 0.08 | 0.023 | 0.08 | Beta 3 adrenoreceptor antagonist | |||
| 0.103 | 0.048 | 0.206 | Interleukin 12 antagonist | 0.206 0.005 CID_154700137 | CID_154700137 | |
| 0.098 | 0.046 | 0.098 | Phosphodiesterase IV inhibitor | |||
| 0.085 | 0.034 | 0.126 | Phosphodiesterase VI inhibitor | 0.126 0.011 CID_154700137 | CID_154700137 | |
| 0.115 | 0.066 | 0.162 | Microtubule formation inhibitor | 0.162 0.032 CID_154700137 | CID_154700137 | |
| 0.067 | 0.018 | 0.067 | Topoisomerase II beta inhibitor | 0.058 0.024 CID_154700137 | ||
| 0.075 | 0.027 | 0.172 | Carbonic anhydrase XII inhibitor | 0.172 0.01 CID_154700137 | CID_154700137 | |
| 0.264 | 0.217 | 0.264 | MAP kinase 1 inhibitor | |||
| 0.106 | 0.06 | 0.106 | Alpha 2c adrenoreceptor antagonist | |||
| 0.123 | 0.077 | 0.123 | Antibacterial (Helicobacter pylori) | |||
| 0.084 | 0.039 | 0.084 | Lipase inhibitor | |||
| 0.085 | 0.041 | 0.085 | GABA aminotransferase inhibitor | 0.079 0.048 CID_154700137 | ||
| 0.074 | 0.032 | 0.074 | Glutamate (mGluR6) antagonist | |||
| 0.056 | 0.014 | 0.056 | GABA B receptor antagonist | |||
| 0.062 | 0.02 | 0.062 | CXC chemokine 1 receptor antagonist | |||
| 0.108 | 0.067 | 0.108 | 5 Hydroxytryptamine 3A agonist | |||
| 0.098 | 0.056 | 0.142 | Phosphodiesterase 6D inhibitor | 0.142 0.012 CID_154700137 | CID_154700137 | |
| 0.056 | 0.017 | 0.056 | DNA-dependent protein kinase inhibitor | |||
| 0.049 | 0.009 | 0.049 | Catechol O-methyltransferase inhibitor | |||
| 0.088 | 0.049 | 0.088 | Glutathione S-transferase inhibitor | |||
| 0.053 | 0.014 | 0.053 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.045 | 0.008 | 0.045 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.063 | 0.025 | 0.09 | Leukotriene B4 antagonist | 0.09 0.013 CID_154700137 | CID_154700137 | |
| 0.057 | 0.019 | 0.057 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.085 | 0.048 | 0.085 | Phosphodiesterase 3A inhibitor | |||
| 0.062 | 0.026 | 0.062 | Leukotriene C antagonist | |||
| 0.094 | 0.058 | 0.094 | ABCA1 expression enhancer | |||
| 0.045 | 0.009 | 0.045 | Protein kinase (CK2) beta inhibitor | |||
| 0.075 | 0.04 | 0.075 | Leukotriene synthesis inhibitor | |||
| 0.056 | 0.021 | 0.056 | Adenylate cyclase 1 inhibitor | |||
| 0.059 | 0.024 | 0.217 | Heparanase inhibitor | 0.217 0.002 CID_154700137 | CID_154700137 | |
| 0.082 | 0.048 | 0.124 | Na+ K+ transporting ATPase inhibitor | 0.124 0.014 CID_154700137 | CID_154700137 | |
| 0.099 | 0.065 | 0.099 | Anabolic | |||
| 0.047 | 0.014 | 0.047 | Sirtuin 2 inhibitor | |||
| 0.098 | 0.065 | 0.098 | Glutamate (mGluR7) agonist | |||
| 0.071 | 0.039 | 0.071 | Dopamine D1 antagonist | |||
| 0.091 | 0.058 | 0.179 | Triose-phosphate isomerase inhibitor | 0.179 0.014 CID_154700137 | CID_154700137 | |
| 0.05 | 0.017 | 0.05 | Estrogen receptor alpha agonist | |||
| 0.066 | 0.034 | 0.066 | CDK4/cyclin D1 inhibitor | |||
| 0.067 | 0.036 | 0.096 | Neuraminidase inhibitor | 0.096 0.017 CID_154700137 | CID_154700137 | |
| 0.058 | 0.027 | 0.111 | Glucose-6-phosphate translocase inhibitor | 0.111 0.005 CID_154700137 | CID_154700137 | |
| 0.069 | 0.039 | 0.069 | Beta adrenoreceptor antagonist | |||
| 0.077 | 0.047 | 0.077 | Glutamate decarboxylase inhibitor | |||
| 0.107 | 0.078 | 0.107 | Proteasome inhibitor | |||
| 0.098 | 0.069 | 0.098 | GABA C receptor agonist | |||
| 0.133 | 0.105 | 0.133 | MAP kinase kinase 4 inhibitor | |||
| 0.275 | 0.248 | 0.275 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.059 | 0.033 | 0.059 | Pregnane X receptor antagonist | |||
| 0.049 | 0.022 | 0.049 | Glutamate (mGluR group III) antagonist | |||
| 0.06 | 0.035 | 0.06 | Carbonic anhydrase VB inhibitor | |||
| 0.076 | 0.051 | 0.076 | Porphobilinogen synthase inhibitor | |||
| 0.076 | 0.051 | 0.076 | GABA B receptor agonist | |||
| 0.025 | 0.005 | 0.042 | Antibiotic Anthracycline-like | 0.042 0.002 CID_154700137 | CID_154700137 | |
| 0.102 | 0.082 | 0.104 | Acetylcholine release stimulant | 0.104 0.078 CID_154700137 | CID_154700137 | |
| 0.055 | 0.035 | 0.055 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.063 | 0.045 | 0.063 | Calcium channel P-type blocker | |||
| 0.055 | 0.036 | 0.055 | DNA helicase inhibitor | |||
| 0.064 | 0.045 | 0.104 | Neuraminidase (influenza) inhibitor | 0.104 0.015 CID_154700137 | CID_154700137 | |
| 0.026 | 0.009 | 0.026 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.058 | 0.042 | 0.058 | Sphingosine kinase inhibitor | |||
| 0.103 | 0.087 | 0.103 | Caspase 3 inhibitor | |||
| 0.077 | 0.062 | 0.077 | Opioid kappa receptor antagonist | |||
| 0.039 | 0.023 | 0.083 | Arginase inhibitor | 0.083 0.005 CID_154700137 | CID_154700137 | |
| 0.061 | 0.046 | 0.061 | 5 Hydroxytryptamine 2A agonist | |||
| 0.042 | 0.028 | 0.042 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.075 | 0.062 | 0.103 | Interferon agonist | 0.103 0.026 CID_154700137 | CID_154700137 | |
| 0.025 | 0.013 | 0.025 | Dopamine D1 agonist | 0.022 0.018 CID_154700137 | ||
| 0.075 | 0.063 | 0.075 | MAP kinase kinase 7 inhibitor | |||
| 0.042 | 0.03 | 0.057 | Guanylate cyclase inhibitor | 0.057 0.014 CID_154700137 | CID_154700137 | |
| 0.038 | 0.027 | 0.038 | Glutamate (mGluR8) agonist | |||
| 0.042 | 0.031 | 0.042 | DNA gyrase subunit A inhibitor | |||
| 0.024 | 0.014 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.19 | 0.181 | 0.19 | Thioredoxin glutathione reductase inhibitor | |||
| 0.04 | 0.03 | 0.04 | Liver X receptor alpha agonist | |||
| 0.032 | 0.024 | 0.032 | Estrogen-related receptor beta antagonist | |||
| 0.121 | 0.114 | 0.121 | Thiol protease inhibitor | |||
| 0.062 | 0.055 | 0.062 | Potassium channel (ATP-sensitive) blocker | |||
| 0.047 | 0.041 | 0.047 | Beta 2 adrenoreceptor antagonist | |||
| 0.067 | 0.061 | 0.067 | Glycine receptor agonist | |||
| 0.037 | 0.032 | 0.037 | Retinoic acid alpha receptor agonist | |||
| 0.082 | 0.077 | 0.082 | Prolactin inhibitor | |||
| 0.03 | 0.025 | 0.03 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.087 | 0.082 | 0.087 | Bile acid receptor antagonist | |||
| 0.022 | 0.018 | 0.022 | Dopamine autoreceptor agonist | |||
| 0.026 | 0.022 | 0.026 | Hedgehog signaling activator | |||
| 0.055 | 0.051 | 0.055 | Cyclin D1 inhibitor | |||
| 0.031 | 0.027 | 0.031 | Glutamate (mGluR3) agonist | |||
| 0.025 | 0.022 | 0.104 | Sodium/glucose cotransporter 2 inhibitor | 0.104 0.003 CID_154700137 | CID_154700137 | |
| 0.029 | 0.026 | 0.029 | Cholesterol ester transfer protein antagonist | |||
| 0.037 | 0.035 | 0.037 | Leukotriene C4 antagonist | |||
| 0.019 | 0.018 | 0.019 | Estrone sulfatase inhibitor | |||
| 0.037 | 0.035 | 0.037 | Dopamine D5 antagonist | |||
| 0.048 | 0.046 | 0.069 | Maillard reaction inhibitor | 0.069 0.029 CID_154700137 | CID_154700137 | |
| 0.105 | 0.104 | 0.105 | Toll-Like receptor 9 antagonist | |||
| 0.043 | 0.042 | 0.063 | Glucose-6-phosphate isomerase inhibitor | 0.063 0.016 CID_154700137 | CID_154700137 | |
| 0.079 | 0.081 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.128 0.015 CID_154700137 | CID_154700137 | |
| 0.056 | 0.061 | 0.13 | Phosphofructokinase-1 inhibitor | 0.13 0.023 CID_154700137 | CID_154700137 | |
| 0.15 | 0.155 | 0.519 | Immunostimulant | 0.519 0.027 CID_154700137 | CID_154700137 | |
| 0.022 | 0.033 | 0.085 | Sodium/glucose cotransporter inhibitor | 0.085 0.003 CID_154700137 | CID_154700137 | |
| 0.052 | 0.064 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.054 CID_154700137 | CID_154700137 | |
| 0.046 | 0.061 | 0.059 | Carbonic anhydrase inhibitor | 0.059 0.047 CID_154700137 | CID_154700137 | |
| 0.074 | 0.093 | 0.104 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.104 0.05 CID_154700137 | CID_154700137 | |
| 0.035 | 0.056 | 0.061 | Carbonic anhydrase IX inhibitor | 0.061 0.037 CID_154700137 | CID_154700137 | |
| 0.148 | 0.168 | 0.297 | Interleukin agonist | 0.297 0.049 CID_154700137 | CID_154700137 | |
| 0.053 | 0.075 | 0.071 | Interferon inducer | 0.071 0.033 CID_154700137 | CID_154700137 | |
| 0.011 | 0.036 | 0.016 | Telomerase stimulant | 0.016 0.014 CID_154700137 | CID_154700137 | |
| 0.103 | 0.13 | 0.299 | Diuretic | 0.299 0.023 CID_154700137 | CID_154700137 | |
| 0.018 | 0.045 | 0.03 | Vanilloid 2 agonist | 0.03 0.01 CID_154700137 | CID_154700137 | |
| 0.015 | 0.044 | 0.06 | Protein 30S ribosomal subunit inhibitor | 0.06 0.006 CID_154700137 | CID_154700137 | |
| 0.036 | 0.073 | 0.058 | Prostaglandin EP2 antagonist | 0.058 0.043 CID_154700137 | CID_154700137 | |
| 0.131 | 0.169 | 0.357 | Platelet antagonist | 0.357 0.036 CID_154700137 | CID_154700137 | |
| 0.038 | 0.078 | 0.083 | Alpha-mannosidase inhibitor | 0.083 0.01 CID_154700137 | CID_154700137 | |
| 0.114 | 0.155 | 0.148 | CC chemokine 6 receptor antagonist | 0.148 0.025 CID_154700137 | CID_154700137 | |
| 0.037 | 0.082 | 0.051 | Cytokine production stimulant | 0.051 0.027 CID_154700137 | CID_154700137 | |
| 0.21 | 0.261 | 0.78 | Cyclophilin D inhibitor | 0.78 0.008 CID_154700137 | CID_154700137 | |
| 0.11 | 0.172 | 0.198 | Interleukin 6 antagonist | 0.198 0.042 CID_154700137 | CID_154700137 | |
| 0.024 | 0.088 | 0.075 | Mannosidase inhibitor | 0.075 0.01 CID_154700137 | CID_154700137 | |
| 0.005 | 0.072 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 CID_154700137 | CID_154700137 | |
| 0.026 | 0.097 | 0.057 | Neuraminidase (Influenza A) inhibitor | 0.057 0.015 CID_154700137 | CID_154700137 | |
| 0.044 | 0.116 | 0.066 | Lipocortins synthesis agonist | 0.066 0.026 CID_154700137 | CID_154700137 | |
| 0.036 | 0.109 | 0.054 | Factor III inhibitor | 0.054 0.026 CID_154700137 | CID_154700137 | |
| 0.049 | 0.136 | 0.084 | Glycine receptor antagonist | 0.084 0.051 CID_154700137 | CID_154700137 | |
| 0.021 | 0.117 | 0.077 | Antibiotic Aminoglycoside-like | 0.077 0.005 CID_154700137 | CID_154700137 | |
| 0.038 | 0.144 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.027 CID_154700137 | CID_154700137 | |
| 0.022 | 0.135 | 0.107 | Protein 50S ribosomal subunit inhibitor | 0.107 0.012 CID_154700137 | CID_154700137 | |
| 0.023 | 0.139 | 0.047 | Microtubule stabilization | 0.047 0.032 CID_154700137 | CID_154700137 | |
| 0.057 | 0.174 | 0.125 | DNA polymerase I inhibitor | 0.125 0.065 CID_154700137 | CID_154700137 | |
| 0.048 | 0.172 | 0.148 | Falcipain 2 inhibitor | 0.148 0.03 CID_154700137 | CID_154700137 | |
| 0.049 | 0.178 | 0.15 | Falcipain inhibitor | 0.15 0.031 CID_154700137 | CID_154700137 | |
| 0.025 | 0.16 | 0.069 | Nitric oxide donor | 0.069 0.035 CID_154700137 | CID_154700137 | |
| 0.049 | 0.238 | 0.132 | Transcription factor NF kappa B stimulant | 0.132 0.02 CID_154700137 | CID_154700137 | |
| 0.065 | 0.255 | 0.212 | Cell wall synthesis inhibitor | 0.212 0.025 CID_154700137 | CID_154700137 | |
| 0.064 | 0.302 | 0.288 | Hypolipemic | 0.288 0.053 CID_154700137 | CID_154700137 | |
| 0.014 | 0.266 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_154700137 | CID_154700137 | |
| 0.014 | 0.279 | 0.343 | Selectin antagonist | 0.343 0.004 CID_154700137 | CID_154700137 | |
| 0.036 | 0.304 | 0.32 | Thrombolytic | 0.32 0.021 CID_154700137 | CID_154700137 | |
| 0.105 | 0.394 | 0.375 | Peptidyltransferase inhibitor | 0.375 0.009 CID_154700137 | CID_154700137 | |
| 0.015 | 0.324 | 0.077 | DNA gyrase inhibitor | 0.077 0.029 CID_154700137 | CID_154700137 | |
| 0.103 | 0.463 | 0.385 | Interleukin 2 agonist | 0.385 0.032 CID_154700137 | CID_154700137 | |
| 0.016 | 0.514 | 0.065 | Factor IXa inhibitor | 0.065 0.023 CID_154700137 | CID_154700137 | |
| 0.025 | 0.533 | 0.247 | Cell adhesion inhibitor | 0.247 0.015 CID_154700137 | CID_154700137 | |
| 0.011 | 0.583 | 0.094 | Cell adhesion molecule inhibitor | 0.094 0.039 CID_154700137 | CID_154700137 | |
| 0.036 | 0.669 | 0.4 | Immunomodulator | 0.4 0.044 CID_154700137 | CID_154700137 | |
| 0.011 | 0.671 | 0.186 | Anticoagulant | 0.186 0.059 CID_154700137 | CID_154700137 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |